These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 27604827)

  • 1. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
    Barrett CS; Millena AC; Khan SA
    Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential role of PTEN in transforming growth factor β (TGF-β) effects on proliferation and migration in prostate cancer cells.
    Kimbrough-Allah MN; Millena AC; Khan SA
    Prostate; 2018 Apr; 78(5):377-389. PubMed ID: 29341212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JunD Is Required for Proliferation of Prostate Cancer Cells and Plays a Role in Transforming Growth Factor-β (TGF-β)-induced Inhibition of Cell Proliferation.
    Millena AC; Vo BT; Khan SA
    J Biol Chem; 2016 Aug; 291(34):17964-76. PubMed ID: 27358408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
    Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
    Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway.
    Vo BT; Morton D; Komaragiri S; Millena AC; Leath C; Khan SA
    Endocrinology; 2013 May; 154(5):1768-79. PubMed ID: 23515290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
    Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
    BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.
    Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH
    Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells.
    Strong N; Millena AC; Walker L; Chaudhary J; Khan SA
    Prostate; 2013 May; 73(6):624-33. PubMed ID: 23060149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of JunB in undifferentiated malignant rat oral keratinocytes enhances the malignant phenotype in vitro without altering cellular differentiation.
    Robinson CM; Prime SS; Huntley S; Stone AM; Davies M; Eveson JW; Paterson IC
    Int J Cancer; 2001 Mar; 91(5):625-30. PubMed ID: 11267971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.
    Vo BT; Cody B; Cao Y; Khan SA
    Carcinogenesis; 2012 Nov; 33(11):2054-64. PubMed ID: 22843506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-β1/ Smad signaling pathway.
    Zhao B; Lu YL; Yang Y; Hu LB; Bai Y; Li RQ; Zhang GY; Li J; Bi CW; Yang LB; Hu C; Lei YH; Wang QL; Liu ZM
    Cancer Biomark; 2018 Feb; 21(3):613-620. PubMed ID: 29278879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblast conditioned media contain TGF-beta1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components.
    Festuccia C; Bologna M; Gravina GL; Guerra F; Angelucci A; Villanova I; Millimaggi D; Teti A
    Int J Cancer; 1999 May; 81(3):395-403. PubMed ID: 10209954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells.
    Miyazawa Y; Sekine Y; Kato H; Furuya Y; Koike H; Suzuki K
    Prostate; 2017 Mar; 77(4):337-349. PubMed ID: 27862098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel role of Giα2 in cell migration: Downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells.
    Caggia S; Chunduri H; Millena AC; Perkins JN; Venugopal SV; Vo BT; Li C; Tu Y; Khan SA
    J Cell Physiol; 2018 Jan; 234(1):802-815. PubMed ID: 30078221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells.
    Nakane K; Fujita Y; Terazawa R; Atsumi Y; Kato T; Nozawa Y; Deguchi T; Ito M
    Int J Urol; 2012 Jan; 19(1):71-9. PubMed ID: 22050448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
    Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
    Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.